<unk>  refers to<unk> rubicin, fludarabine, high-dose cytarabine (AraC) and filgrastim (G-CSF), used as a remission-induction treatment for for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia.
FLAG-Ida regimen
Mito-FLAG regimen
ACVBP-R regimen
FLAG regimen
FLAMSA-BU regimen
FLAMSA regimen
R-GCVP regimen
FMC-R regimen